Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1987
05/13/1987EP0221700A2 A thrombin preparation
05/13/1987EP0221588A2 Brain-specific drug delivery
05/13/1987EP0221566A2 Method for preparing antihemophilic factor (AHF) by cold precipitation and for improving solubility of recovered AHF product
05/13/1987EP0221561A2 Antigen indicative of human breast cancer and assays based thereon
05/13/1987EP0221426A2 Method of preparing alpha-1-proteinase inhibitor
05/13/1987EP0221173A1 Diagnostic reagents based on unique sequences within the variable region of the t cell receptor and uses thereof
05/12/1987US4665192 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
05/12/1987US4665189 Oxiranes
05/12/1987US4665161 Process for producing highly purified HCG
05/12/1987US4665159 High titer varicella-zoster immune globulin for intravenous administration
05/12/1987US4665158 Method for hydrolyzing protein materials
05/12/1987US4665157 Oligopeptide analgesics
05/12/1987US4665055 Peptide renin inhibitors
05/12/1987US4665054 Glycyl-histidyl-lysine copper chelate
05/12/1987US4665053 Hydrophobic carboxylic modifier
05/12/1987US4665052 Homophenylalanine, hypotensives, antialdosterones
05/12/1987CA1221635A1 Composition with an improved pharmaceutical activity and use as veterinary drug
05/07/1987WO1987002697A1 Supercritical fluid extraction of animal derived materials
05/07/1987WO1987002677A1 Isoforms of soluble immune response suppressor
05/07/1987WO1987002676A1 Conformationally constrained oxytocin antagonists with prolonged biological activities
05/07/1987WO1987002675A1 Difluorocyclostatine containing polypeptides
05/07/1987WO1987002674A1 Analogs of atrial natriuretic peptides
05/07/1987WO1987002673A2 Process for activating heterologous, eucaryotic proteins genetically engineered and presenting disulphide bridges after their expression in procaryotic cells
05/07/1987WO1987002671A1 Modular assembly of antibody genes, antibodies prepared thereby and use
05/07/1987WO1987002585A2 Treating increased intraocular pressure caused by steroids
05/07/1987WO1987002581A1 Renin inhibitors and methods for using same
05/06/1987EP0221019A2 Peptides
05/06/1987EP0220958A2 Selective chemical removal of a protein amino-terminal residue
05/06/1987EP0220957A2 Platelet binding inhibitors
05/06/1987EP0220899A1 Bifunctional linker
05/06/1987EP0220865A2 Lactam derivatives, their preparation and their use as hypotensive agents
05/06/1987EP0220665A2 Peptides
05/06/1987EP0220657A2 Conjugate of 9-(2-hydroxyethoxymethyl)-guanine with lactosaminated human albumin, process for the peparation thereof and pharmaceutical compositions containing it
05/06/1987EP0220654A2 Gonadoliberine analogues, process for preparing them, pharmaceutical composition and use
05/06/1987EP0220574A1 Human interferon beta2A, vectors containing genes coding for said interferon, cell lines producing same
05/06/1987EP0220537A1 Pharmaceutical composition containing thymus extract fractions
05/06/1987EP0220482A1 Novel plasmid and use thereof
05/06/1987EP0220309A1 Method for augmenting immune response
05/06/1987EP0220308A1 Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
05/06/1987CN85107873A Monoclonal antibodies against metal chelates
05/05/1987US4663438 Novel nucleic acid-containing glycoprotein
05/05/1987US4663437 Atrial natriuretic peptide
05/05/1987US4663435 Release inhibitors for hormones, insulin
05/05/1987US4663342 Antitumor
05/05/1987US4663310 Renin inhibitors containing 2-substituted statine
05/05/1987US4663309 Novel peptide hormones with calcitonin-like activity
05/05/1987US4663164 Aqueous compositions for treating blood clotting factor inhibitors
04/1987
04/29/1987EP0220157A2 Mitogenic peptides
04/29/1987EP0220107A2 Use of angiotensin-converting enzyme inhibitors in macular degeneration
04/29/1987EP0220030A2 Oral delivery system
04/29/1987EP0219979A2 Treating animals using IL-2, formulations therefor and their preparation
04/29/1987EP0219874A2 Process for activating recombinant heterologous eucaryotic disulfide-bridged proteins after expression by procaryotes
04/29/1987EP0219839A2 Interleukin-2 derivative, its preparation and use
04/29/1987EP0219782A2 Use of angiotensin-converting enzyme inhibitors in the treatment of atherosclerosis, thrombosis and peripheral vascular disease
04/29/1987EP0219781A2 Biologically active human gamma interferon derivatives, their preparation and drugs containing such derivatives
04/29/1987EP0219716A2 Immunosuppressive agent
04/28/1987US4661586 Monoclonal anti-idiotype antibodies
04/28/1987US4661479 Enzyme inhibitors
04/28/1987US4661473 Hypotensive agents
04/28/1987US4661472 GnRH antagonists IX
04/28/1987US4661471 Administering low molecular weight peptide
04/28/1987US4661470 Ester derivatives of antibiotic L 17046
04/28/1987US4661469 t-PA composition capable of being absorbed into the blood stream and method of administration
04/28/1987US4661347 Cytotoxic compositions
04/28/1987US4661346 Immunological compositions including a peptide and osmium or ruthenium tetroxide
04/28/1987CA1221030A1 Allograft of reduced immunogenicity and method and reagent for making same
04/28/1987CA1221029A1 Plasminogen activator, its preparation process and thrombolytic agent containing same
04/28/1987CA1221028A1 Material for use in the treatment of spontaneous abortions
04/23/1987WO1987002384A1 Expression systems for overproduction of desired proteins
04/23/1987WO1987002368A1 New mammal protein having an immunomodulating and progestational activity
04/23/1987WO1987002251A1 Oral delivery of biologically active substances bound to vitamin b12, or analogues thereof
04/23/1987WO1987002247A1 Rapid acting intravenous emulsions of omega-3 fatty acid esters
04/23/1987WO1987002243A1 A composition for treating and preventing diarrhoea in humans andanimals and a method of preparing same
04/23/1987WO1987002219A1 Alpha tocopherol-based vesicles
04/23/1987DE3537460A1 Derivatives of bicyclic amino acids, process for their preparation, compositions containing these and their use
04/22/1987EP0219400A1 Glycopeptides and glycoproteins, any composition containing them, method for their preparation, and anticoagulation applications thereof
04/22/1987EP0219295A2 Process for producing human growth hormone
04/22/1987EP0219275A2 Vasopressin compounds
04/22/1987EP0219270A2 Method of enhancing tissue plasminogen activator and single chain urokinase plasminogen activator production
04/22/1987EP0219258A2 Peptide antagonists of Neurokinin B and opthalmic solutions containing them
04/22/1987EP0219106A2 Polypeptides that elicit antibodies against AIDS virus
04/22/1987EP0219073A2 Stabilization of interferons
04/22/1987EP0218900A2 Osmotic agents for peritoneal dialysis
04/22/1987EP0218868A2 Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
04/22/1987EP0218825A1 Cysteine-depleted muteins of interferon-beta, their preparation, formulations containing them, and structural genes, vectors and organisms, and their production, suitable for use in the preparation of said muteins
04/22/1987EP0218717A1 Recombinant inhibin
04/22/1987EP0218696A1 Human anti-inflammatory phospholipase inhibitor protein
04/22/1987EP0218692A1 Von willebrand factor
04/22/1987EP0218650A1 Pharmacologically active peptides
04/21/1987US4659805 Recombinant alveolar surfactant protein
04/21/1987US4659804 (Bis-1,7-S-acetamidomethyl-L-cysteine)salmon calcitonin
04/21/1987US4659695 Method of treatment of prostate cancer
04/21/1987US4659694 Polypeptide hormone for prevention of infections
04/21/1987US4659692 Cationic oligopeptides having microbicidal activity
04/21/1987US4659691 Novel cyclic Hexapeptide LHRH antagonists
04/21/1987US4659660 Culturing streptomyces toyocaensis nrrl under submerged aerobic fermentation conditions
04/21/1987US4659570 Preparation containing stabilized physiologically active substance
04/21/1987US4659563 High titer anti-respiratory syncytial virus intravenous immune globulin
04/21/1987US4658830 Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
04/21/1987CA1220746A1 Luzopeptin e.sub.2